🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 09075P105
- Market Cap
- Small Cap
- IPO
- 3/7/2018 · $11.00/share
Business: BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices.
Company Contact
- CEO
- Vimal Mehta, Ph.D.
- CFO
- Richard I. Steinhart
- Headquarters
- 555 Long Wharf Drive, New Haven, CT 06511
- Phone
- 475-238-6837
- Investor Relations
- Erik Kopp · 203-494-7062 · ekopp@bioxceltherapeutics.com